Cumberland Pharmaceuticals, which sells specialty pharmaceuticals, including a new injectable treatment for pain and fever, raised $85 million by offering 5,000,000 shares at $17.00, below the expected range of $19.00 to $21.00. The Nashville, TN-based company...read more
Cumberland Pharmaceuticals, which sells specialty pharmaceuticals to the hospital and gastroenterology markets, raised the proposed deal size for its upcoming IPO on Friday. The Nashville,TN-based company now plans to raise $100 million by offering 5 million...read more
Cumberland Pharmaceuticals, which focuses on the acquisition of branded prescription products in hospital acute care and gastroenterology, filed terms Monday for its upcoming IPO. The company plans to offer 6.3 million shares at a price range of $14 to $16. ...read more
Cumberland Pharmaceuticals prices IPO at $17, below the range
Cumberland Pharmaceuticals, which sells specialty pharmaceuticals, including a new injectable treatment for pain and fever, raised $85 million by offering 5,000,000 shares at $17.00, below the expected range of $19.00 to $21.00. The Nashville, TN-based company...read more
Upcoming IPOs: Cumberland Pharmaceuticals, Emdeon, Starwood Property Trust
The following IPOs are expected to price this week:
...read more
Cumberland Pharmaceuticals increases proposed IPO deal size
Cumberland Pharmaceuticals, which sells specialty pharmaceuticals to the hospital and gastroenterology markets, raised the proposed deal size for its upcoming IPO on Friday. The Nashville,TN-based company now plans to raise $100 million by offering 5 million...read more
Cumberland Pharmaceuticals announces terms
Cumberland Pharmaceuticals, which focuses on the acquisition of branded prescription products in hospital acute care and gastroenterology, filed terms Monday for its upcoming IPO. The company plans to offer 6.3 million shares at a price range of $14 to $16. ...read more